Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Teva Pharmaceuticals Nyse Discount, 56% OFF | espirituviajero.com
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma